Molecular pathogen detection - miami VAMC
Active Awarded Last action
- Contract number
- 36C24826N0293
- Awardee
-
Biomerieux Inc. UEI HCNVCMEG9NL6
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $705,369
Award facts
- Contract value 100% obligated
- $705,368.52 Current and potential, with all options
- Completion date 77% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Miami, FL 33125, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$76,745 | |
| Original award | $782,113 |
About this award
Biomerieux Inc., operating through its Vitek Systems, Inc. division, received a firm fixed-price delivery order award from Veterans Integrated Service Network 8 (VISN 8) on January 13, 2026, valued at $705,368.52 for molecular pathogen detection equipment and services at the Miami Veterans Affairs Medical Center in Miami, Florida. The award, which carries an ultimate completion date of January 12, 2027, was issued without a set-aside designation, reflecting Biomerieux's status as a specialized sole-source provider of proprietary diagnostic technologies. This delivery order represents a de-obligation of fiscal year 2026 funds to refine quantities for the molecular pathogen detection initiative, leveraging Biomerieux's established capabilities in microorganism identification and molecular diagnostic platforms.
This award builds on Biomerieux's extensive contract portfolio with the Department of Veterans Affairs across multiple VISNs, where the company supplies advanced diagnostic equipment, reagents, test kits, and maintenance services. The Miami VAMC delivery order likely includes components from Biomerieux's proprietary VITEK, BioFire, or VIDAS diagnostic platforms along with associated consumables and potentially maintenance services. The contract was issued under Biomerieux's established relationship with VISN 8, consistent with the company's role as a critical supplier of infectious disease testing and molecular pathogen detection capabilities supporting the VA healthcare system's clinical laboratory operations.
Quick answers
Who was awarded contract 36C24826N0293?
36C24826N0293 was awarded to Biomerieux Inc. by Veterans Integrated Service Network 8 (Veterans Health Administration) on January 13, 2026.
How much is contract 36C24826N0293 worth?
The government has obligated $705,369 on 36C24826N0293.
Is contract 36C24826N0293 an order under another contract?
Yes. 36C24826N0293 is a delivery order under 36C24825D0014, an indefinite delivery contract.
Was contract 36C24826N0293 competed?
The extent of competition for 36C24826N0293 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award